These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7994865)

  • 1. Thromboembolism after negative TEE.
    Manning WJ; Silverman DI; Douglas PS
    Circulation; 1994 Dec; 90(6):3121-2. PubMed ID: 7994865
    [No Abstract]   [Full Text] [Related]  

  • 2. Is it safe to cardiovert atrial fibrillation without anticoagulation if the transoesophageal echocardiogram is normal?
    Chambers J
    Int J Cardiol; 1998 Jan; 63(2):107-9. PubMed ID: 9510482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioversion related thromboembolism: value of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation.
    Seidl K; Senges J
    Card Electrophysiol Rev; 2003 Dec; 7(4):392-6. PubMed ID: 15071262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients undergoing cardioversion of atrial flutter should be routinely anticoagulated.
    Densèm CG
    Am J Cardiol; 1999 Jan; 83(1):140-1. PubMed ID: 10073808
    [No Abstract]   [Full Text] [Related]  

  • 5. Transesophageal echocardiography during cardioversion of atrial fibrillation.
    Omran H; Lüderitz B
    Am J Cardiol; 2001 Jan; 87(1):126. PubMed ID: 11202314
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-molecular-weight heparin in transesophageal echocardiography-guided cardioversion of atrial fibrillation.
    Wodlinger AM; Pieper JA
    Pharmacotherapy; 2003 Jan; 23(1):57-63. PubMed ID: 12523460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anticoagulation with low molecular weight heparins within the framework of cardioversion for atrial fibrillation].
    Tebbe U
    Dtsch Med Wochenschr; 2007 Sep; 132(39):2033-6. PubMed ID: 17882745
    [No Abstract]   [Full Text] [Related]  

  • 8. [Atrial fibrillation and cardioversion: role of transesophageal echocardiography].
    Moreo A; Mauri F
    Ital Heart J Suppl; 2005 Dec; 6(12):780-7. PubMed ID: 16444922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anticoagulation in atrial fibrillation before cardioversion].
    Stellbrink C; Hanrath P
    Dtsch Med Wochenschr; 1999 Apr; 124(13):407. PubMed ID: 10226651
    [No Abstract]   [Full Text] [Related]  

  • 10. Strategies for cardioversion of atrial fibrillation--time for a change?
    Silverman DI; Manning WJ
    N Engl J Med; 2001 May; 344(19):1468-70. PubMed ID: 11346813
    [No Abstract]   [Full Text] [Related]  

  • 11. Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. A multicenter study.
    Black IW; Fatkin D; Sagar KB; Khandheria BK; Leung DY; Galloway JM; Feneley MP; Walsh WF; Grimm RA; Stollberger C
    Circulation; 1994 Jun; 89(6):2509-13. PubMed ID: 8205657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of embolic events after cardioversion of atrial fibrillation. Current and evolving strategies.
    Kinch JW; Davidoff R
    Arch Intern Med; 1995 Jul; 155(13):1353-60. PubMed ID: 7794083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-cardioversion transesophageal echocardiography (POSTEC) strategy with the use of enoxaparin for brief anticoagulation in atrial fibrillation patients: the multicenter POSTEC trial (a pilot study).
    Sorino M; Colonna P; De Luca L; Carerj S; Oliva E; De Tommasi SM; Conti U; Iacopi F; D'Agostino C; D'Amato N; Pettinati G; Montericcio V; Cualbu A; De Luca I
    J Cardiovasc Med (Hagerstown); 2007 Dec; 8(12):1034-42. PubMed ID: 18163016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is early cardioversion of atrial fibrillation, facilitated by transesophageal echocardiography, safe and effective?
    Arthur M; Greenawald MH
    J Fam Pract; 2001 Nov; 50(11):925. PubMed ID: 11711003
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of transesophageal echocardiography in cardioversion of atrial fibrillation].
    Schvartzman PR; Manfroi WC; Pinotti A
    Arq Bras Cardiol; 1998 Feb; 70(2):131-4. PubMed ID: 9659722
    [No Abstract]   [Full Text] [Related]  

  • 16. [The role of transesophageal echocardiography in deciding the treatment patients with atrial fibrillation].
    Bykova ES; Golitsyn SP; At'kov OIu
    Ter Arkh; 2001; 73(8):77-80. PubMed ID: 11599276
    [No Abstract]   [Full Text] [Related]  

  • 17. Experience in daily clinical practice of ambulatory cardioversion of atrial fibrillation treated with new oral anticoagulants.
    Santas E; Méndez J; Martínez-Brotons A; Núñez J; Chorro FJ; Ruiz-Granell R
    Rev Esp Cardiol (Engl Ed); 2014 Nov; 67(11):960-1. PubMed ID: 25242661
    [No Abstract]   [Full Text] [Related]  

  • 18. [Stroke and other thromboembolic complications of atrial fibrillation. Part VII. Prevention of cardioversion related thromboembolism].
    Preobrazhenskiĭ DV; Sidorenko BA; Kiktev VG; Batyraliev TA; Pershukov IV
    Kardiologiia; 2005; 45(7):78-82. PubMed ID: 16091669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ineffective anticoagulation prior to elective electric cardioversion for atrial fibrillation. Results of transesophageal echocardiography].
    Stopp M; Kristen C; Sybrecht GW; Jung J
    Dtsch Med Wochenschr; 2003 Jun; 128(23):1277-81. PubMed ID: 12789636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of transesophageal echocardiography in the therapeutic management of non-valvular atrial fibrillation].
    Baubion N
    Arch Mal Coeur Vaiss; 1996 Oct; 89(10):1291-5. PubMed ID: 8952827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.